280 related articles for article (PubMed ID: 7691404)
21. Significance of spontaneous apoptosis during colorectal tumorigenesis.
Koike M
J Surg Oncol; 1996 Jun; 62(2):97-108. PubMed ID: 8649048
[TBL] [Abstract][Full Text] [Related]
22. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
23. Expression of CD44 splice variants in colorectal cancer.
Wong LS; Cantrill JE; Morris AG; Fraser IA
Br J Surg; 1997 Mar; 84(3):363-7. PubMed ID: 9117309
[TBL] [Abstract][Full Text] [Related]
24. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
25. Inverse association of cell adhesion regulator messenger RNA expression with metastasis in human colorectal cancer.
Yamamoto H; Itoh F; Hinoda Y; Imai K
Cancer Res; 1996 Aug; 56(15):3605-9. PubMed ID: 8758933
[TBL] [Abstract][Full Text] [Related]
26. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer.
Di Renzo MF; Olivero M; Giacomini A; Porte H; Chastre E; Mirossay L; Nordlinger B; Bretti S; Bottardi S; Giordano S
Clin Cancer Res; 1995 Feb; 1(2):147-54. PubMed ID: 9815967
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma.
Sanjuán X; Fernández PL; Miquel R; Muñoz J; Castronovo V; Ménard S; Palacín A; Cardesa A; Campo E
J Pathol; 1996 Aug; 179(4):376-80. PubMed ID: 8869283
[TBL] [Abstract][Full Text] [Related]
28. [Expression of CD44 metastatic variant mRNA in colorectal carcinomas and its role in tumor metastasis and invasion].
Sugaya Y; Harigaya K
Nihon Rinsho; 1995 Jul; 53(7):1699-703. PubMed ID: 7630010
[TBL] [Abstract][Full Text] [Related]
29. Loss of KAI1 expression in the progression of colorectal cancer.
Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
31. Expression of the ets-1 proto-oncogene in human colorectal carcinoma.
Nakayama T; Ito M; Ohtsuru A; Naito S; Sekine I
Mod Pathol; 2001 May; 14(5):415-22. PubMed ID: 11353051
[TBL] [Abstract][Full Text] [Related]
32. Altered expression of KCNK9 in colorectal cancers.
Kim CJ; Cho YG; Jeong SW; Kim YS; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
APMIS; 2004 Sep; 112(9):588-94. PubMed ID: 15601307
[TBL] [Abstract][Full Text] [Related]
33. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors.
Yoshida K; Bolodeoku J; Sugino T; Goodison S; Matsumura Y; Warren BF; Toge T; Tahara E; Tarin D
Cancer Res; 1995 Oct; 55(19):4273-7. PubMed ID: 7545538
[TBL] [Abstract][Full Text] [Related]
34. Limitations of CD44v6 amplification for the detection of tumour cells in the blood of colorectal cancer patients.
Masson D; Denis MG; Lustenberger P
Br J Cancer; 2000 Apr; 82(7):1283-9. PubMed ID: 10755402
[TBL] [Abstract][Full Text] [Related]
35. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas.
Ishiguro K; Yoshida T; Yagishita H; Numata Y; Okayasu T
Gut; 2006 May; 55(5):695-702. PubMed ID: 16354798
[TBL] [Abstract][Full Text] [Related]
36. Expression of standard CD44 in human colorectal carcinoma: association with prognosis.
Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK
Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas.
Chuang CK; Liao SK
Anticancer Res; 2003; 23(6C):4635-9. PubMed ID: 14981907
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
[TBL] [Abstract][Full Text] [Related]
39. Expression of CD44 splice variants during lymphocyte activation and tumor progression.
Griffioen AW; Horst E; Heider KH; Wielenga VJ; Adolf GR; Herrlich P; Pals ST
Cell Adhes Commun; 1994 Jul; 2(3):195-200. PubMed ID: 7530151
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms.
Zhang W; Hart J; McLeod HL; Wang HL
Am J Clin Pathol; 2005 Jul; 124(1):11-9. PubMed ID: 15923159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
